Skip to main content
Attovia Therapeutics, Inc. (ATTO)
NASDAQ: ATTO · Real-Time Price · USD
15.13
-0.68 (-4.30%)
At close: Nov 13, 2026, 4:00 PM EST
15.22
+0.08 (0.56%)
After-hours: Nov 13, 2026, 4:10 PM EST

Attovia Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Cash & Equivalents
115.3740.1930.63
Short-Term Investments
280.57112.0838.69
Cash & Short-Term Investments
395.94152.2769.32
Cash Growth
-119.65%-
Other Receivables
-0.90.1
Receivables
-0.90.1
Prepaid Expenses
8.583.133.06
Total Current Assets
404.52156.372.48
Property, Plant & Equipment
6.327.873.23
Other Long-Term Assets
0.991.731
Total Assets
411.82165.8976.72

Liabilities

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Accounts Payable
4.233.554.14
Accrued Expenses
5.355.093.58
Current Portion of Leases
2.11.92-
Current Unearned Revenue
-0.45-
Total Current Liabilities
11.6711.017.72
Long-Term Leases
1.743.34-
Other Long-Term Liabilities
0.670.766.87
Total Liabilities
14.0815.114.59

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Common Stock
0.0100
Additional Paid-In Capital
570.913.473.49
Retained Earnings
-172.62-111.01-50.38
Comprehensive Income & Other
-0.550.10.07
Total Common Equity
397.74-107.44-46.83
Shareholders' Equity
397.74150.7962.13
Total Liabilities & Equity
411.82165.8976.72

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024
Period Ending
Sep '26 Dec '25 Dec '24
Total Debt
3.845.26-
Net Cash (Debt)
392.1147.0169.32
Net Cash Growth
-112.06%-
Net Cash Per Share
37.2337.2219.63
Filing Date Shares Outstanding
45.714.434.43
Total Common Shares Outstanding
45.684.434.43
Working Capital
392.85145.2964.76
Book Value Per Share
8.71-24.27-10.58
Tangible Book Value
397.74-107.44-46.83
Tangible Book Value Per Share
8.71-24.27-10.58
Machinery
-4.431.96
Construction In Progress
-0.031.57
Leasehold Improvements
-0.14-
SEC Filings: 10-K · 10-Q